Trial Profile
A Phase 3 Study of JNS020QD in Patients With Chronic Pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Aug 2013
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Pain
- Focus Registrational; Therapeutic Use
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Dec 2012 Actual initiation date changed from Aug 2011 to Oct 2011 as reported by ClinicalTrials.gov.
- 29 Mar 2012 Planned end date changed from 1 Jan 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.